References
- Long M. W. Blood cell cytoadhesion molecules. Exp. Hematol. 1992; 20: 288–301
- Sanchez-Madrid F., Nagy J. A., Robbins E., Simon P., Springer T. A. A human leukocyte differentiation antigen family with distinct alpha subunits and a common beta subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1) and the pi50,95 molecule. J. Exp. Med. 1983; 158: 1785–1803
- Krensky A. M., Sanchez-Madrid F., Robbins E., Nagy J., Springer T. A., Burakoff S. J. The functional significance, distribution and structure of LFA-1, LFA-2 and LFA-3: cell surface antigens associated with CTL-target interactions. J. Immunol. 1983; 131: 611–616
- Rothlein R., Dustin M. L., Marlin S. D., Springer T. A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 1986; 137: 1270–1274
- Staunton D. E., Dustin M. L., Springer T. A. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989; 339: 61–64
- Inghirami G., Wieczorek R., Bang-Ying, Zhu Silver R., Dalla-Favera R., Knowles D. M. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood 1988; 72: 1431–1434
- Medeiros L. J., Weiss L. M., Picker L. J., Clayberger C., Horning S. J., Krensky A. M., Warnke R. A. Expression of LFA-1 in non-Hodgkin's lymphoma. Cancer 1989; 63: 255–259
- Billaud M., Rousset F., Calender A., Cordier M., Aubry J. P., Laisse V., Lenoir G. M. Low expression of Lymphocyte Function-Associated (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and nor associated with Epstein-Barr virus. Blood 1990; 75: 1827–1833
- Stauder R., Greil S., Schulz T. F., et al. Expression of LFA-1 and 7F7 antigen, an adhesion molecule related to ICAM-1, in non-Hodgkin's lymphomas and leukemias: possible influence on growth pattern and leukemic behaviour. Clin. Exp. Immunol. 1989; 77: 234–238
- De Paoli P., Basaglia G., Genari D., Santini G. Differential expression of LFA-1 alpha molecule in clinical stages of chronic B-lymphocytic leukemia patients. Eur. J. Haematol. 1990; 45: 234–235
- De Rossi G., Mandelli F., Zarcone G., Cerruti Mauro F. R., Grossi C. 5th International Workshop on CLL. Sitges-Barcelona, Spain. Abstr. Book 1991; 31
- Manson D. Y. Immunocytochemical labelling of monoclonal antibodies by the APAAP immunoalkaline phosphatase technique. Techniques in Immunocytochemistry, G. Bullock, H. Petrusz. Academic Press, London 1985; vol. 3: 25
- Van Riet I., De Waele M., Remels L., Lacor P., Schots R., Van Camp B. Expression of cytoadhesion molecules (CD56, CD54, CD 18 and CD 19) by myeloma plasma cells. Br. J. Haematol. 1991; 79: 421–427
- Horts E., Radaszkiewicz T., Hooftman-deu Otter A., et al. Expression of the leukocyte integrins LFA-1 (CD1 1a/CD 19) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage differentiation but not to tumor grade. Leukemia 1991; 5: 848–853
- Horts E., Meijer C. J., Radaszkiewicz T., Ossekoppele G. J., Van Krieken J. H., Pals S. T. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CDlla/CD18), and ICAM-1 (CD54). Leukemia 1990; 4: 595–599
- Clayberger C., Medeiros L. J., Link M. P., et al. Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet 1987; ii: 533–536
- Miedema F., Tromp J. F., Van't Veer M. B., Poppema S., Melief C. J. Lymphocyte function-associated antigen-1 (LFA-1) is a marker of mature (immunocompetent) lymphoid cells. A survey of lymphoproliferative diseases in man. Leuk. Res. 1985; 9: 1099–1104
- Baldini L., Cro L., Calori R., Nobili L., Silvestris I., Mariolo A. Differential expression of very late activation antigen VLA-3/VLA-4 in B cell non-Hodgkin lymphoma and B cell chronic lymphocytic leukemia. Blood 1992; 15: 2688–2693
- Springer T. A., Thompson W. S., Miller L. J., Schmal-Stieg F. C., Anderson D. C. Inherited deficiency of the Mac-1, LFA-1, p-150, 95 glycoprotein family and its molecular basis. J. Exp. Med. 1984; 160: 1901–1914
- Erikstein B. K., Holte H., Kva10y S, Andersson K. B., Steen H. B., Hannisdal E., Smeland E. B. Expression of CD 18 (integrin beta-2 chain) correlates with prognosis in malignant B cell lymphomas. Br. J. Haematol. 1993; 83: 392–398
- Rabinowitz R., Polliack A., Leizerowitz R., Keren-Zur Y., Schlesinger M. Expression of CD1 la (LFA-1) on B-chronic lymphocytic leukemia and lymphoma cells: correlation with cell surface immunoglobulin intensity and CD58 (LFA-3) expression. Leukemia and Lymphoma 1991, Suppl: 59–64